Outcomes with sacubitril/valsartan in outpatients with heart failure and reduced ejection fraction: The ARIADNE registry-Reference-Cited by-同舟云学术

Outcomes with sacubitril/valsartan in outpatients with heart failure and reduced ejection fraction: The ARIADNE registry

Published:2022-09-15 Issue:6 Volume:9 Page:4209-4218
ISSN:2055-5822
Container-title:ESC Heart Failure
language:en
Short-container-title:ESC Heart Failure

Author:

Maggioni Aldo P.¹^ORCID,Clark Andrew L.²,Barrios Vivencio³,Damy Thibaud⁴,Drozdz Jaroslaw⁵,Fonseca Candida⁶,Lund Lars H.⁷,Kalus Stefanie⁸,Ferber Philippe C.⁹,Hussain Rizwan I.¹⁰,Koch Cornelia⁹,Zeymer Uwe¹¹,

Affiliation:

1. Heart Care Foundation ANMCO Research Centre Florence Italy

2. Hull University Teaching Hospitals NHS Trust Hull UK

3. University Hospital Ramon y Cajal Madrid Spain

4. University Hospital Henri Mondor Créteil France

5. Medical University of Lodz Lodz Poland

6. Hospital de Sao Francisco Xavier, Lisbon, NOVA Medical School, Faculdade de Ciências Médicas Universidade Nova de Lisboa Lisbon Portugal

7. Department of Medicine Karolinska Institutet and Karolinska University Hospital Stockholm Sweden

8. GKM Gesellschaft für Therapieforschung mbH Munich Germany

9. Novartis Pharma Basel Switzerland

10. Arxx Therapeutics Oslo Norway

11. Klinikum Ludwigshafen and Institut für Herzinfarktforschung Ludwigshafen‐am‐Rhein Germany

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ehf2.14014

Reference21 articles.

1. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure;McDonagh TA;Eur Heart J 2021

2. European Society of Cardiology Heart Failure Long‐Term Registry ( ESC‐HF‐LT ): 1‐year follow‐up outcomes and differences across regions

3. Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure

4. Management of heart failure with reduced ejection fraction in Europe: design of the ARIADNE registry

5. Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC Heart Failure Long-Term Registry

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characteristics and outcomes of heart failure in Japan: A hospital‐based administrative database analysis;ESC Heart Failure;2024-09-03

2. Efficacy and Safety of Sacubitril/Valsartan in Hemodialysis Patients with Chronic Heart Failure: A Retrospective Study at a Single Center;Medical Science Monitor;2024-06-10

3. Comparison of the Efficacy and Safety of Sacubitril/Valsartan and Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Patients With Reduced Ejection Fraction Combined With Moderate-to-Severe Chronic Kidney Disease;Journal of Cardiovascular Pharmacology and Therapeutics;2024-01

4. Guideline-Recommended Therapy Following Hospitalization for Heart Failure;JACC: Heart Failure;2023-10

5. conTemporary reflectiOns regarding heart failure manaGEmenT – How to ovERcome the PorTuguese barriers (TOGETHER-PT);Revista Portuguesa de Cardiologia;2023-09